
1/n A webinar from @CDC_Genomics on Mendelian randomization (MR) highlights some under-appreciated aspects of MR; this thread outlines these youtube.com/watch?v=pc3uQz06…


1/n A webinar from @CDC_Genomics on Mendelian randomization (MR) highlights some under-appreciated aspects of MR; this thread outlines these youtube.com/watch?v=pc3uQz06…

Is the story of shingles vaccine preventing dementia just too good to be true?
We have a commentary out on some really interesting findings by colleagues in UCL and Finland on some of the maths behind some of the high profile shingles -> dementia analyses. In brief + Paper: pubmed.ncbi.nlm.nih.gov/4245… Commentary: kwnsfk27.r.eu-west-1.awstrac…

Great opportunity to join team @gushamilton
Funded GW4 PhD available to apply for with me and Bill Horsnell, looking at early life infection in ALSPAC and asthma with PhiP-Seq. Will be v cool data! gw4biomed.ac.uk/early-life-i…

This is one of the reasons I have been going on about this cefepime/pip-tazo story. The weight of RCT evidence suggests pip-tazo is a *superior* agent. Yet a bunch of observational studies suggest some anti-anaerobic activity is harmful. It's pretty clear what we should trust!
Finally it's published! 🆕🔥🟢Systematic Review and Bayesian Meta-Analysis @DrToddLee What is the association of cefepime with all-cause mortality compared with other β-lactam antibiotics? This systematic review and bayesian meta-analysis found that cefepime was associated with higher odds of all-cause mortality compared with other β-lactams Meta-analysis of published peer-reviewed RCTs (73 trials, 15 411 patients) showed that cefepime was associated with a 98.6% posterior probability of higher mortality compared with other β-lactams (OR, 1.17; 95% credible interval, 1.02-1.34). Posterior distributions generally favored higher odds of mortality across all comparator β-lactams, across all clinical indications, and with doses of 2 g or more every 12 hours. #idxposts jamanetwork.com/journals/jam…

Commentary from VP on our study. A nice summary of the whole literature from the outside and a good explanation of RD. One further point is the degree of analytic choices in RD in empiric settings that make them more variable than RCTs.
Does the Shingles Vaccine Reduce Dementia?

I enjoyed giving the annual "distinguished lecture" on triangulation of evidence at Cambridge Uni Medical school, particularly as I could remind them at the beginning that they had tried to throw me out when I was a clinical medical student there youtu.be/e2ttItEnwCU

A long thread on a quasi experimental study modelled on the @Nature paper using Welsh data and suggesting live shingles vaccine protects against dementia. Sadly in 20 times the sample size using precisely the same quasi experimental design we showed no such apparent protection
Does the (live) shingles vaccine protect against dementia? We provide important evidence in a new preprint using hospital data from the whole of England in a regression discontinuity design where we *don't* show strong evidence of a causal effect +

Note: this was in the Xmas BMJ .. make of that what you will

With England vs Argentina in the world cup don’t get too excited if it gets to a penalty shoot out .. here an analysis of the 1998 shoot out vs Argentina using regression discontinuity shows increase in heart attacks pubmed.ncbi.nlm.nih.gov/1249…

Keir Starmer and Alexander Kerensky: compare and contrast in 300 characters. Win the most banal Ted Talk of all time

The evidence for this is rather not consistent Please watch this whole video from master of causal inference @mendel_random:
How strong is the evidence that live shingles vaccination prevents the risk of dementia? A talk yesterday @oxprimarycare on this available here youtu.be/qlTnnQytOJ0

Pro Tip - if someone appears to know and state confident opinions about everything, especially areas outside of their expertise, they should be consistently ignored
Perhaps @EricTopol should watch this all the way through? youtu.be/qlTnnQytOJ0?si=hTpO… We show with 20 times the sample size the original supposedly “huge” RDD @Nature paper does not replicate and why so-called “target trials” are just rebranded observational epidemiology.

Perhaps @EricTopol should watch this all the way through? youtu.be/qlTnnQytOJ0?si=hTpO… We show with 20 times the sample size the original supposedly “huge” RDD @Nature paper does not replicate and why so-called “target trials” are just rebranded observational epidemiology.
Yet another study shows a 24% reduced risk of dementia after the Shingles vaccine. This one in over 500,000 participants with a recent skilled nursing facility stay, adding to 4 huge natural experiments in 4 countries (US, Canada, Wales, and Australia) acpjournals.org/doi/10.7326/… @AnnalsofIM

Here's the talk @JeremyFarrar youtu.be/qlTnnQytOJ0 Interested in your take on it ....
George - will the lecture be available on line, live or afterwards? 🙏

How strong is the evidence that live shingles vaccination prevents the risk of dementia? A talk yesterday @oxprimarycare on this available here youtu.be/qlTnnQytOJ0

Thx Jeremy, yes it is available on line - need to fill out the registration and tick online option at the end @JeremyFarrar
George - will the lecture be available on line, live or afterwards? 🙏